PL3886908T3 - Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych - Google Patents
Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowychInfo
- Publication number
- PL3886908T3 PL3886908T3 PL19836474.7T PL19836474T PL3886908T3 PL 3886908 T3 PL3886908 T3 PL 3886908T3 PL 19836474 T PL19836474 T PL 19836474T PL 3886908 T3 PL3886908 T3 PL 3886908T3
- Authority
- PL
- Poland
- Prior art keywords
- phospholipids
- dispersion
- preparation
- fatty acid
- acid salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18209472 | 2018-11-30 | ||
| PCT/EP2019/082919 WO2020109472A1 (en) | 2018-11-30 | 2019-11-28 | Preparation comprising a dispersion of phospholipids and fatty acid salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3886908T3 true PL3886908T3 (pl) | 2025-09-29 |
Family
ID=64564653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19836474.7T PL3886908T3 (pl) | 2018-11-30 | 2019-11-28 | Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12194012B2 (pl) |
| EP (1) | EP3886908B1 (pl) |
| JP (1) | JP7438216B2 (pl) |
| KR (1) | KR20210097153A (pl) |
| CN (1) | CN113164611B (pl) |
| AU (1) | AU2019386289B2 (pl) |
| BR (1) | BR112021010240A2 (pl) |
| CA (1) | CA3121055C (pl) |
| DK (1) | DK3886908T3 (pl) |
| ES (1) | ES3038235T3 (pl) |
| MX (1) | MX2021006263A (pl) |
| PL (1) | PL3886908T3 (pl) |
| WO (1) | WO2020109472A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102405390B1 (ko) | 2016-07-13 | 2022-06-03 | 에보닉 오퍼레이션스 게엠베하 | 용해된 지질을 함유하는 바이오매스로부터 지질을 분리하는 방법 |
| DK3562925T3 (da) | 2016-12-27 | 2021-05-25 | Evonik Operations Gmbh | Fremgangsmåde til isolering af lipider fra en lipidholdig biomasse |
| CA3072846A1 (en) | 2017-08-17 | 2019-02-21 | Evonik Operations Gmbh | Enhanced production of lipids by limitation of at least two limiting nutrient sources |
| EP3470502A1 (en) | 2017-10-13 | 2019-04-17 | Evonik Degussa GmbH | Method of separating lipids from a lysed lipids containing biomass |
| EP3527664A1 (en) | 2018-02-15 | 2019-08-21 | Evonik Degussa GmbH | Method of isolating lipids from a lipids containing biomass |
| CN112166176B (zh) | 2018-05-15 | 2024-06-25 | 赢创运营有限公司 | 借助疏水性二氧化硅从含有脂质的生物质中分离脂质的方法 |
| BR112020023222A2 (pt) | 2018-05-15 | 2021-03-23 | Evonik Operations Gmbh | método de isolamento de lipídios a partir de uma biomassa contendo lipídios lisados por inversão por emulsão |
| WO2023080712A1 (ko) * | 2021-11-05 | 2023-05-11 | ㈜아이엠디팜 | 신규한 서방성 지질 전구 제제 및 이를 포함하는 서방성 주사용 약학 조성물 |
| WO2025098952A1 (en) * | 2023-11-07 | 2025-05-15 | Evonik Operations Gmbh | Nutrient preloading of cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616594C2 (de) * | 1986-05-16 | 1994-07-28 | Kampffmeyer Muehlen | Backmittel für Brötchenteige |
| US5015483A (en) * | 1989-02-09 | 1991-05-14 | Nabisco Brands, Inc. | Liposome composition for the stabilization of oxidizable substances |
| JPH06157294A (ja) * | 1992-11-19 | 1994-06-03 | Tanabe Seiyaku Co Ltd | 脂肪微粒子製剤 |
| JPH06183954A (ja) * | 1992-12-24 | 1994-07-05 | Kyowa Hakko Kogyo Co Ltd | リポソーム製剤 |
| IT1264987B1 (it) | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
| US20070042008A1 (en) * | 2005-08-18 | 2007-02-22 | Bodybio, Inc. | Compositions containing phosphatidylcholine and essential fatty acids |
| PT2144618E (pt) * | 2007-03-28 | 2013-07-08 | Aker Biomarine Asa | Composições bioeficazes de óleo de krill |
| ES2979118T3 (es) | 2009-03-09 | 2024-09-24 | Basf As | Composiciones que comprenden una mezcla de aceites de ácidos grasos y un ácido graso libre, y procedimientos y usos de las mismas |
| WO2011137160A2 (en) | 2010-04-30 | 2011-11-03 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| US10798962B2 (en) * | 2014-12-23 | 2020-10-13 | Evonik Operations Gmbh | Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids |
| WO2016149386A1 (en) * | 2015-03-16 | 2016-09-22 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Biomarkers for malaria diagnosis |
| WO2017155386A1 (en) | 2016-03-08 | 2017-09-14 | N.V. Nutricia | Method for treating brain atrophy |
-
2019
- 2019-11-28 MX MX2021006263A patent/MX2021006263A/es unknown
- 2019-11-28 KR KR1020217019809A patent/KR20210097153A/ko active Pending
- 2019-11-28 ES ES19836474T patent/ES3038235T3/es active Active
- 2019-11-28 WO PCT/EP2019/082919 patent/WO2020109472A1/en not_active Ceased
- 2019-11-28 AU AU2019386289A patent/AU2019386289B2/en active Active
- 2019-11-28 JP JP2021529680A patent/JP7438216B2/ja active Active
- 2019-11-28 CN CN201980078485.7A patent/CN113164611B/zh active Active
- 2019-11-28 US US17/294,835 patent/US12194012B2/en active Active
- 2019-11-28 CA CA3121055A patent/CA3121055C/en active Active
- 2019-11-28 EP EP19836474.7A patent/EP3886908B1/en active Active
- 2019-11-28 DK DK19836474.7T patent/DK3886908T3/da active
- 2019-11-28 BR BR112021010240-0A patent/BR112021010240A2/pt unknown
- 2019-11-28 PL PL19836474.7T patent/PL3886908T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019386289B2 (en) | 2025-04-24 |
| MX2021006263A (es) | 2021-07-06 |
| BR112021010240A2 (pt) | 2021-08-17 |
| CA3121055A1 (en) | 2020-06-04 |
| JP7438216B2 (ja) | 2024-02-26 |
| US12194012B2 (en) | 2025-01-14 |
| CN113164611B (zh) | 2024-06-25 |
| JP2022509814A (ja) | 2022-01-24 |
| KR20210097153A (ko) | 2021-08-06 |
| CA3121055C (en) | 2024-04-16 |
| WO2020109472A1 (en) | 2020-06-04 |
| ES3038235T3 (en) | 2025-10-10 |
| CN113164611A (zh) | 2021-07-23 |
| EP3886908B1 (en) | 2025-06-04 |
| EP3886908A1 (en) | 2021-10-06 |
| US20220016065A1 (en) | 2022-01-20 |
| AU2019386289A1 (en) | 2021-07-15 |
| DK3886908T3 (da) | 2025-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3886908T3 (pl) | Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych | |
| IL291055A (en) | Stable formulations of lipids and liposomes | |
| IL283480A (en) | Solid forms of lometaferon and lometaferon salts and processes for preparing lometaferon | |
| EP3821720A4 (en) | Microencapsulated conjugated linoleic acid glyceride powder and preparation method thereof | |
| IL261989A (en) | A pharmaceutical preparation of flavociclib and a method for its preparation | |
| IL277683A (en) | Mono-salts of 6-aminoquinoline and their uses | |
| EP3259483A4 (en) | Furniture parts comprising a male part and a female part of a joint | |
| IL234104A0 (en) | A method for the preparation of triglycerides of medium chain fatty acids | |
| IL247529B (en) | Preparations of choline ester lipoic acid and methods of use | |
| SG11202009315WA (en) | Formulation and method of preparation | |
| SG11201803022TA (en) | Compositions comprising fatty acids and their use | |
| EP3852544A4 (en) | COMPOSITIONS AND METHODS FOR INTRODUCING ODD-CHAIN FATTY ACIDS INTO POULTRY EGGS | |
| EP3318261A4 (en) | Use of zoledronic acid to prepare drug treating fatty liver disease | |
| ZA202103212B (en) | Composition comprising a choline salt of a fatty acid and its use as a fungicide | |
| PL3463310T3 (pl) | Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3 | |
| EP3307250A4 (en) | Glycopyrronium fatty acid salts and methods of making same | |
| GB2561121B (en) | Branched acid emulsifier compositions and methods of use | |
| GB201717564D0 (en) | Universal adpater for a plug connector head and plug connector part having a plug connector head of this kind | |
| IL324298A (en) | Using nor-ursodeoxycholic acid to reduce liver fat | |
| PL3471702T3 (pl) | Stabilne formulacje z lipidami bakteriobójczymi | |
| HUE045829T2 (hu) | Lényegében transz-zsírsavaktól mentes ehetõ emulzió | |
| PL3331497T3 (pl) | Preparat nawilżający pochodnej karbamoiloetylowej katiry i sposób jego wytwarzania | |
| AU2019385698B2 (en) | Composition comprising a choline salt of a fatty acid and its use as a fungicide | |
| HK1260612A1 (en) | Treatments of accumulated fat with deoxycholic acid and salts thereof | |
| HK1228199A1 (en) | Lipoic acid choline ester compositions and methods of use |